Biocompatible biodegradable fumagillin analog conjugates

Details for Australian Patent Application No. 2008331516 (hide)

Owner Mersana Therapeutics, Inc.

Inventors Akullian, Laura C.; Petter, Russell C.; Stevenson, Cheri A.; Hammond, Charles E.; Yurkovetskiy, Aleksandr; Yin, Mao; Kane, John J.

Agent FB Rice

Pub. Number AU-A-2008331516

PCT Pub. Number WO2009/073445

Priority 61/004,582 28.11.07 US

Filing date 24 November 2008

Wipo publication date 11 June 2009

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C07D 303/22 (2006.01) Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

10 June 2010 PCT application entered the National Phase

  PCT publication WO2009/073445 Priority application(s): WO2009/073445

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008331520-Construction system

2008331507-Conjugates of anti-RG-1 antibodies